Real-world efficacy of biological agents in moderate-to-severe plaque psoriasis: An analysis of 75 patients in Taiwan.
<h4>Background</h4>Real-world clinical data on psoriasis patients receiving different biological agents is needed, especially in Asian populations.<h4>Objectives</h4>Our aim is to compare and analyze the efficacy and safety profile of four biological agents (etanercept, adali...
Main Authors: | Yu-Chen Chen, Yi-Ting Huang, Chao-Chun Yang, Edward Chia-Cheng Lai, Cheng-Han Liu, Chao-Kai Hsu, Tak-Wah Wong, Sheau-Chiou Chao, Hamm-Ming Sheu, Chaw-Ning Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0244620 |
Similar Items
-
Health-related quality of life among patients with moderate-to-severe plaque psoriasis in Taiwan
by: Tsen-Fang Tsai, et al.
Published: (2018-12-01) -
Patient's perception and importance of clear/almost clear skin in moderate-to-severe plaque psoriasis: Results of clear about psoriasis survey in Taiwan
by: Yu-Huei Huang, et al.
Published: (2019-01-01) -
Cutaneous lymphomas in Taiwan: A review of 118 cases from a medical center in southern Taiwan
by: Chaw-Ning Lee, et al.
Published: (2018-03-01) -
Long-term efficacy and safety of guselkumab in Chinese patients with moderate-to-severe plaque psoriasis
by: Jianfeng Zheng, et al.
Published: (2023-12-01) -
Tinea nigra due to Hortaea werneckii in Taiwan
by: Yi-Chen Liao, et al.
Published: (2022-06-01)